Private Equity 8 Hours

Last updated: May 22, 2026, 8:30 AM ET

IPO Activity & European Fundraising Filed for a NY listing as Oura, the Finnish smart‑ring maker, submitted an S‑1 that projects a valuation north of $1bn, underscoring growing investor appetite for health‑tech wearables. At the same time, the €5bn Scaleup Europe Fund disclosed a pipeline of more than 100 potential portfolio companies, signaling a broadening of capital to later‑stage European innovators. Across the Channel, EQT announced plans to deploy the same €5bn super‑fund into UK‑based startups, a move that could channel fresh growth capital into Britain’s tech ecosystem despite ongoing market volatility targeted UK startups.

Sector‑Specific Private‑Equity Moves Targeted pain‑management assets as Charterhouse Capital, Iron Path and Revelar Capital each closed deals to build platforms and execute add‑on acquisitions, reflecting a trend toward niche healthcare sub‑sectors that promise resilient cash flows. In parallel, Avista and the family‑office‑backed Damier Group agreed to acquire Belgian vitamins producer Sanotact, adding a consumer‑health brand to their growing European health‑goods portfolio acquired Sanotact. Meanwhile, Partners Group’s Todd Miller outlined a “total‑return” strategy focused on mature heavy‑industry and traditional sectors, a niche that he argues remains under‑served by yield‑oriented private‑equity funds launched yield‑focused strategy.

Tech Landscape & Regulatory Shifts Mapped 60+ legaltech startups across Europe, illustrating rapid digitisation of law‑firm workflows and attracting early‑stage investors seeking scalable Saa S models. The same region saw the release of a Southern Europe 2026 leaderboard, where investors such as Accel, Atomico and Index Ventures topped the ranking, highlighting concentrated capital in Spain, Italy and Portugal’s emerging markets identified top investors. Finally, the European Commission’s accelerated overhaul of the AI Act introduced stricter risk‑assessment obligations for high‑impact systems, a regulatory change that private‑equity firms will need to factor into due‑diligence for AI‑enabled portfolio companies rewrote AI rules.